Type 2 Diabetes Mellitus: From Insulin Resistance and β-Cell Failure to Management

Authors

  • Amira Sobhy Mahmoud , Heba Sabry Ahmed, Nevertyty Mohamed Mahmoud, Dalia M. Abd El Motteleb Author

DOI:

https://doi.org/10.48047/4rczgz89

Keywords:

Type 2 diabetes mellitus, Insulin resistance, β-cell dysfunction, Pharmacotherapy

Abstract

Background:  Type 2 diabetes mellitus (T2DM) is a heterogeneous metabolic disorder in which insulin resistance, progressive β-cell 
dysfunction, altered glucagon biology, adipose tissue dysfunction, ectopic lipid deposition, inflammation, and disturbed energy sensing interact over years before overt hyperglycemia appears. The therapeutic landscape has changed markedly, moving from a glucose-centered approach toward simultaneous control of glycemia,

Downloads

Download data is not yet available.

References

Galicia-Garcia U, Benito-Vicente A, Jebari S, et al. Pathophysiology of type 2 diabetes mellitus. Int J Mol Sci. 2020;21(17):6275.

Abouzid MR, Ali K, Elkhawas I, Elshafei SM. An overview of diabetes mellitus in Egypt and the significance of integrating preventive cardiology in diabetes management. Cureus. 2022;14(7):e27066.

Downloads

Published

2024-11-20

How to Cite

Type 2 Diabetes Mellitus: From Insulin Resistance and β-Cell Failure to Management (Amira Sobhy Mahmoud , Heba Sabry Ahmed, Nevertyty Mohamed Mahmoud, Dalia M. Abd El Motteleb , Trans.). (2024). Cuestiones De Fisioterapia, 53(03), 8519-8525. https://doi.org/10.48047/4rczgz89